EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines

Helen Y Lorenzo-Anota, Alejandra Reyes-Ruiz, Kenny M Calvillo-Rodríguez, Rodolfo Mendoza-Reveles, Andrea P Urdaneta-Peinado, Karla M Alvarez-Valadez, Ana Carolina Martínez-Torres, Cristina Rodríguez-Padilla

EXCLI Journal · 16.03.2023 · 22 · 352-366

DOI: 10.17179/excli2022-5568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 16.03.2023. Verfasst von Helen Y Lorenzo-Anota und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, México. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IMMUNEPOTENT CRP (ICRP) is an immunotherapy that induces cell death in cancer cell lines. However, the molecular mechanisms of death are not completely elucidated. Here, we evaluated the implication of intracellular Ca2+ augmentation in the cell death induced by ICRP on T-ALL and breast cancer cell lines. Cell death induction and the molecular characteristics of cell death were evaluated in T-ALL and breast cancer cell lines by assessing autophagosome formation, ROS production, loss of mitochondrial membrane potential, ER stress and intracellular Ca2+ levels. We assessed the involvement of extracellular Ca2+, and the implication of the ER-receptors, IP3R and RyR, in the cell death induced by ICRP, by using an extracellular calcium chelator and pharmacological inhibitors. Our results show that ICRP increases intracellular Ca2+ levels as the first step of the cell death mechanism that provokes ROS production and loss of mitochondrial membrane potential. In addition, blocking the IP3 and ryanodine receptors inhibited ER-Ca2+ release, ROS production and ICRP-induced cell death. Taken together our results demonstrate that ICRP triggers intracellular Ca2+-increase leading to different regulated cell death modalities in T-ALL and breast cancer cell lines.

Schlagwörter

Stichwörter der Autor:innen

IP3 receptorcalciumcancercell deathimmunotherapyryanodine receptor

Autor:innen und Institutionen

  • Laboratorio de Inmunología y Virología, Facultad de Ciencias Biológicas, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, México.
  • Tecnológico de Monterrey, The Institute for Obesity Research, Monterrey, México.
  • LONGEVEDEN S.A. de C.V.

Zitieren

APA

Lorenzo-Anota, H. Y., Reyes-Ruiz, A., Calvillo-Rodríguez, K. M., Mendoza-Reveles, R., Urdaneta-Peinado, A. P., Alvarez-Valadez, K. M., Martínez-Torres, A. C., & Rodríguez-Padilla, C. (2023). IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines. EXCLI Journal, 22, 352-366. https://doi.org/10.17179/excli2022-5568

Vancouver

Lorenzo-Anota HY, Reyes-Ruiz A, Calvillo-Rodríguez KM, Mendoza-Reveles R, Urdaneta-Peinado AP, Alvarez-Valadez KM, et al. IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines. EXCLI Journal. 2023;22:352-366. doi:10.17179/excli2022-5568

BibTeX
@article{LorenzoAnota2023,
  author = {Lorenzo-Anota, Helen Y and Reyes-Ruiz, Alejandra and Calvillo-Rodríguez, Kenny M and Mendoza-Reveles, Rodolfo and Urdaneta-Peinado, Andrea P and Alvarez-Valadez, Karla M and Martínez-Torres, Ana Carolina and Rodríguez-Padilla, Cristina},
  title = {IMMUNEPOTENT CRP increases intracellular calcium through ER-calcium channels, leading to ROS production and cell death in breast cancer and leukemic cell lines},
  journal = {EXCLI Journal},
  year = {2023},
  volume = {22},
  pages = {352--366},
  doi = {10.17179/excli2022-5568}
}
Kostenlos starten →